ET
JAZZ icon

Entropy Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Entropy Technologies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,942
Closed -$556K – 1087
2026
Q1 		$556K Sell
2,942
-25,521
-90% -$4.46M 0.03% 564
2025
Q4 		$4.84M Buy
+28,463
New +$4.36M 0.26% 111
2024
Q3 		– Sell
-7,394
Closed -$789K – 835
2024
Q2 		$789K Buy
7,394
+3,312
+81% +$364K 0.09% 282
2024
Q1 		$492K Sell
4,082
-2,206
-35% -$270K 0.05% 448
2023
Q4 		$773K Buy
+6,288
New +$785K 0.14% 245

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Entropy Technologies's JAZZ Position: Q2 2026 in Review

Entropy Technologies sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 2,942 shares — an estimated $556K sold.

Entropy Technologies first reported a position in JAZZ in Q4 2023 and held it in 5 quarters. The position peaked at $4.84M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Entropy Technologies reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Entropy Technologies sold 2,942 Jazz Pharmaceuticals shares in Q2 2026, an estimated $556K.
  • Entropy Technologies first reported a position in Jazz Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Entropy Technologies's Jazz Pharmaceuticals position peaked at $4.84M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.